![Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy | npj Precision Oncology Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-017-0034-x/MediaObjects/41698_2017_34_Fig1_HTML.jpg)
Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy | npj Precision Oncology
![Frontiers | Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission Frontiers | Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission](https://www.frontiersin.org/files/Articles/713694/fcvm-08-713694-HTML/image_m/fcvm-08-713694-g001.jpg)
Frontiers | Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission
![PDF) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio- Oncology Society (IC-OS) PDF) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio- Oncology Society (IC-OS)](https://i1.rgstatic.net/publication/362963968_2022_ESC_Guidelines_on_cardio-oncology_developed_in_collaboration_with_the_European_Hematology_Association_EHA_the_European_Society_for_Therapeutic_Radiology_and_Oncology_ESTRO_and_the_International_C/links/630c5d1361e4553b95479032/largepreview.png)
PDF) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio- Oncology Society (IC-OS)
![Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week - ScienceDirect Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719339300-fx1.jpg)
Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week - ScienceDirect
![Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of](https://onlinelibrary.wiley.com/cms/asset/25fa44cf-a349-4a0c-b159-60f29503ba63/ejhf1920-fig-0002-m.jpg)
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of
Impact Factor Results Rank JACC Journals Among Top 12 Cardiovascular Journals Worldwide - American College of Cardiology
![Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia | Nature Reviews Cardiology Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-020-0348-1/MediaObjects/41569_2020_348_Fig1_HTML.png)